FLI1 |
hemogenic endothelium |
dox |
Permissive
Robust
|
Mus musculus |
GSE40235
...
|
MA0475.2
|
FLI1 |
embryonic stem cell-derived hemogenic endothelium |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0475.2
|
FLI1 |
embryonic stem cell-derived hematopoietic progenitors |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0475.2
|
FLI1 |
embryonic stem cell-derived macrophages |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0475.2
|
FLI1 |
leukemic cells |
DNMT3A overexpression |
Permissive
Robust
|
Mus musculus |
GSE80724
...
|
MA0475.2
|
FLI1 |
bone marrow-derived macrophages |
No treatment |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 4 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 12 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
Passage: 15-19 |
Permissive
Robust
|
Homo sapiens |
GSE99959
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
Passage: 15-19 |
Permissive
Robust
|
Homo sapiens |
GSE99959
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
Passage: 15-19 |
Permissive
Robust
|
Homo sapiens |
GSE99959
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
Passage: 15-19 |
Permissive
Robust
|
Homo sapiens |
GSE99959
...
|
MA0475.2
|
FLI1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0475.2
|
FLI1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: JQ1, no DOX, uniduced |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0475.2
|
FLI1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0475.2
|
FLI1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0475.2
|
FLI1 |
EWS-FLI1-induced murine Ewing sarcoma cells |
Treatment: no Strain: Balb/c |
Permissive
|
Mus musculus |
GSE108631
...
|
MA0475.2
|
FLI1 |
Ba/F3-Mpl |
Cell type: murine pro B cell line Genotype: expressing Empty vector |
Permissive
Robust
|
Mus musculus |
GSE120134
...
|
MA0475.2
|
FLI1 |
Ba/F3-Mpl |
Cell type: murine pro B cell line Genotype: expressing WT Calreticuline (CALR) |
Permissive
|
Mus musculus |
GSE120134
...
|
MA0475.2
|
FLI1 |
Ba/F3-Mpl |
Cell type: murine pro B cell line Genotype: expressing del Calreticuline (CALR) |
Permissive
|
Mus musculus |
GSE120134
...
|
MA0475.2
|
FLI1 |
Ba/F3-Mpl |
Cell type: murine pro B cell line Genotype: expressing INS Calreticuline (CALR) |
Permissive
|
Mus musculus |
GSE120134
...
|
MA0475.2
|
FLI1 |
EWS502 (Ewing sarcoma) |
|
Permissive
|
Homo sapiens |
GSE31838
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE31838
...
|
MA0475.2
|
FLI1 |
embryonic stem cell-derived haematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE22178
...
|
MA0475.2
|
FLI1 |
megakaryocytes |
|
Permissive
Robust
|
Homo sapiens |
GSE24674
...
|
MA0475.2
|
FLI1 |
CD8+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0475.2
|
FLI1 |
CD8+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0475.2
|
FLI1 |
Th2-cells |
|
Permissive
|
Mus musculus |
GSE20898
...
|
MA0475.2
|
FLI1 |
megakaryocyte |
|
Permissive
Robust
|
Mus musculus |
ENCSR000DHD
...
|
MA0475.2
|
FLI1 |
hematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE40235
...
|
MA0475.2
|
FLI1 |
hematopoietic progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE40235
...
|
MA0475.2
|
FLI1 |
CD34+ hematopoietic stem cells |
|
Permissive
Robust
|
Homo sapiens |
GSE45144
...
|
MA0475.2
|
FLI1 |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0475.2
|
FLI1 |
mature megakaryocytes |
|
Permissive
Robust
|
Mus musculus |
GSE42108
...
|
MA0475.2
|
FLI1 |
acute myeloid leukemia |
|
Permissive
Robust
|
Mus musculus |
GSE66122
...
|
MA0475.2
|
FLI1 |
416B (hematopoietic precursor cells) |
|
Permissive
Robust
|
Mus musculus |
GSE69776
...
|
MA0475.2
|
FLI1 |
leukemic cells |
|
Permissive
Robust
|
Mus musculus |
GSE80724
...
|
MA0475.2
|
FLI1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE76464
...
|
MA0475.2
|
FLI1 |
Hoxb8-FL |
|
Permissive
Robust
|
Mus musculus |
GSE84328
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE106914
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE106914
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE106914
...
|
MA0475.2
|
FLI1 |
A-673 clone Asp114 (Ewing sarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE106914
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE109695
...
|
MA0475.2
|
FLI1 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE109695
...
|
MA0475.2
|
FLI1 |
NB4 (acute promyelocytic leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE23730
|
MA0475.2
|
FLI1 |
SKNO-1 (acute myeloid leukemia) |
|
Permissive
|
Homo sapiens |
GSE23730
|
MA0475.2
|
FLI1 |
ME-1 (acute myeloid leukemia ) |
|
Permissive
|
Homo sapiens |
GSE46044
|
MA0475.2
|
FLI1 |
TSU-1621-MT (adult acute myeloid leukemia) |
|
Permissive
|
Homo sapiens |
GSE60477
|
MA0475.2
|
FLI1 |
|
ZINC |
Permissive
Robust
|
Homo sapiens |
GSE23730
|
MA0475.2
|
FLI1 |
SK-N-MC (Askin tumor) |
SHFLI_48H |
Permissive
Robust
|
Homo sapiens |
GSE61944
|
MA0475.2
|
FLI1 |
SK-N-MC (Askin tumor) |
SHFLI_96H |
Permissive
Robust
|
Homo sapiens |
GSE61944
|
MA0475.2
|
FLI1 |
SK-N-MC (Askin tumor) |
SHGFP_48H |
Permissive
Robust
|
Homo sapiens |
GSE61944
|
MA0475.2
|
FLI1 |
SK-N-MC (Askin tumor) |
SHGFP_96H |
Permissive
Robust
|
Homo sapiens |
GSE61944
|
MA0475.2
|
FLI1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE23730
|
MA0475.2
|
FLI1 |
SK-N-MC (Askin tumor) |
|
Permissive
Robust
|
Homo sapiens |
GSE61944
|
MA0475.2
|